Successful adalimumab graded challenge after allergic delayed reaction to golimumab in a woman with rheumatoid arthritis

A graded challenge with adalimumab could be safe in case of a delayed allergic reaction to golimumab, after a detailed allergological evaluation and the exclusion of allergic sensitization using skin tests.

Detalles Bibliográficos
Autores principales: Rivolta, Federica, Sangalli, Andrea, Cappelletti, Camilla, Chiei Gallo, Alessandra, Dubini, Marco, Pravettoni, Valerio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037302/
https://www.ncbi.nlm.nih.gov/pubmed/36968346
http://dx.doi.org/10.1002/ccr3.7067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037302/
https://www.ncbi.nlm.nih.gov/pubmed/36968346
http://dx.doi.org/10.1002/ccr3.7067

Ejemplares similares